| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/24/2015 | US8962658 Fluoralkylcarbonyl-oxadiazoles |
| 02/24/2015 | US8962657 Aryl derivatives and uses thereof |
| 02/24/2015 | US8962636 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 02/24/2015 | US8962618 Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof |
| 02/24/2015 | US8962601 Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids |
| 02/24/2015 | US8962593 GLA monotherapy for use in cancer treatment |
| 02/24/2015 | US8962568 Treatment of T-cell mediated diseases |
| 02/24/2015 | US8962558 Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3 |
| 02/24/2015 | US8962547 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 02/24/2015 | US8962324 Method and system for treatment of biological tissue |
| 02/24/2015 | US8962262 Method of protein extraction from cells |
| 02/24/2015 | US8962239 Methods useful for vitamin D deficiency and related disorders |
| 02/24/2015 | US8962043 Visual performance and/or macular pigmentation |
| 02/24/2015 | US8962042 Methods for treating neurological disorders using nutrient compositions |
| 02/24/2015 | US8962041 Methods and compositions for enhancing hair quality using blackberry extract |
| 02/24/2015 | US8962038 Nitrite formulations and their use as nitric oxide prodrugs |
| 02/24/2015 | US8962034 Antiviral therapy with a whole, leech saliva extract |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8962009 Sustained release intraocular implants and related methods |
| 02/24/2015 | US8961988 Compositions and methods for the treatment or prevention of hepatitis B virus infection |
| 02/24/2015 | US8961963 Pharmacological composition whereby statin and COQ10 compounds are enhanced |
| 02/24/2015 | US8961959 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 02/24/2015 | US8961957 Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10 |
| 02/24/2015 | CA2679206C Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| 02/24/2015 | CA2636288C Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 02/24/2015 | CA2585317C Drug combination for the treatment of depression and related disorders comprising a selective serotonin reuptake inhibitor |
| 02/19/2015 | WO2015023507A2 Methods for increasing forced expiratory volume in asthmatics using benralizumab |
| 02/19/2015 | WO2015022874A1 Hydrogen-containing antimicrobial agent |
| 02/19/2015 | WO2015022497A1 Adjuvants in anti-cancer chemotherapy |
| 02/19/2015 | WO2015022386A1 Combined pharmaceutical preparation for use in treating neuromuscular disorders |
| 02/19/2015 | US20150051299 Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists |
| 02/19/2015 | US20150051261 Methods of Treating Fatty Liver Disease |
| 02/19/2015 | US20150051244 Antibacterial quinoline derivatives |
| 02/19/2015 | US20150051199 Pharmaceutical compounds |
| 02/19/2015 | US20150051191 Treatment of alcoholism using ibudilast |
| 02/19/2015 | US20150051189 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/19/2015 | US20150051182 Methods and related compositions for reduction of fat and skin tightening |
| 02/19/2015 | US20150051179 Novel steroidal cyp17 inhibitors/antiandrogens |
| 02/19/2015 | US20150051166 Methods of Treating Neurological Diseases |
| 02/19/2015 | US20150051154 Alkylating agents |
| 02/19/2015 | US20150051145 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| 02/19/2015 | US20150051143 Compositions and methods for treating non-alcoholic steatohepatitis |
| 02/19/2015 | US20150051140 Modification of feeding behavior |
| 02/19/2015 | US20150050620 Preventing or treating periodontal disease |
| 02/19/2015 | US20150050371 Extract Formulations of Rhodamnia Cinerea And Uses Thereof |
| 02/19/2015 | US20150050367 Timosaponin compounds |
| 02/19/2015 | US20150050356 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 02/19/2015 | US20150050355 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 02/19/2015 | US20150050346 Compositions and methods for treating insulin resistance and diabetes mellitus |
| 02/19/2015 | US20150050344 Compositions and methods for upregulating hippocampal plasticity and hippocampus-dependent learning and memory |
| 02/19/2015 | US20150050342 Compositions for treatment of skin disorders |
| 02/19/2015 | US20150050329 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
| 02/19/2015 | US20150050327 Liposome formulation suitable for treating or preventing tuberculosis |
| 02/19/2015 | US20150050325 Organic compounds |
| 02/19/2015 | US20150050304 CD4+ T Survivin Epitopes and Uses Thereof |
| 02/19/2015 | US20150050293 Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome |
| 02/19/2015 | US20150050288 Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3 |
| 02/19/2015 | US20150050283 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/19/2015 | US20150050275 Purification of anti-c-met antibodies |
| 02/19/2015 | US20150050263 Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System |
| 02/19/2015 | US20150050259 Nutraceutical modulators of stem cell activity |
| 02/19/2015 | US20150050248 Multifunctional immature dental pulp stem cells and therapeutic applications |
| 02/19/2015 | US20150050239 Substituted pyrazolone compounds and methods of use |
| 02/19/2015 | US20150050238 Treatment of osteoarthritis and pain |
| 02/19/2015 | US20150050237 New anti-mycobacterial drugs against tuberculosis |
| 02/19/2015 | US20150050215 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 02/19/2015 | US20150050210 Pharmaceutical formulation comprising bendamustine |
| 02/18/2015 | EP2837390A1 Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders |
| 02/18/2015 | EP2837389A1 Medicinal composition for treating infarction |
| 02/18/2015 | EP2837379A1 Dosage form comprising a 5-alpha-reductase steroid inhibitor and an alpha blocker, process for the preparation of a dosage form, use of dosage form, method for the treatment or prophylaxis of a disease or condition mediated by androgen |
| 02/18/2015 | EP2836224A2 Compositions of microbiota and methods related thereto |
| 02/18/2015 | EP2836204A1 Aggregate particles |
| 02/17/2015 | US8957203 Hepatitis C virus inhibitors |
| 02/17/2015 | US8957103 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 02/17/2015 | US8957095 Treatment of sunburn using analgesics and antihistamines |
| 02/17/2015 | US8957085 Carboxamide bioisosteres of opiates |
| 02/17/2015 | US8957080 Tyrosine kinase inhibitors |
| 02/17/2015 | US8957079 Inhibitors of Bruton's tyrosine kinase |
| 02/17/2015 | US8957076 Wound healing |
| 02/17/2015 | US8957064 Fused pyrimidines |
| 02/17/2015 | US8957060 Tumescent antibiotic solution |
| 02/17/2015 | US8957047 GLA monotherapy for use in cancer treatment |
| 02/17/2015 | US8957033 Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof |
| 02/17/2015 | US8957024 Composition and methods for reducing opioid-induced pruritus |
| 02/17/2015 | US8957014 Sensitization of tumor cells to radiation therapy through administration of endothelin agonists |
| 02/17/2015 | US8956664 Methods and compositions for treating mucositis |
| 02/17/2015 | US8956663 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 02/17/2015 | US8956652 Effervescent rehydrating beverage tablet/granules |
| 02/17/2015 | US8956627 Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates |
| 02/17/2015 | US8956618 Vaccine vectors and methods of enhancing immune responses |
| 02/17/2015 | US8956613 Gemcitabine prodrugs and uses thereof |
| 02/17/2015 | US8956611 Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease |
| 02/17/2015 | CA2655509C Steroid-containing sustained release intraocular implants and related methods |
| 02/17/2015 | CA2611389C Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/17/2015 | CA2506129C 2'-branched nucleosides and flaviviridae mutation |
| 02/12/2015 | WO2015020212A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/12/2015 | WO2015020040A1 Medicine for preventing or suppressing survival of cancer cells and having organic acid polymer as active ingredient |
| 02/12/2015 | WO2015018659A1 Glutamine synthetase inhibitors for inhibition of pathological angiogenesis |
| 02/12/2015 | WO2015018471A1 Pni (psychoneuroimmunium) lobbyist cell protection |
| 02/12/2015 | WO2015018375A1 Depression regulatory factor and applications thereof |